Hemophilia B Gene Therapy With AAV8 Vector

NCT01620801 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Spark Therapeutics, Inc.

Collaborators